Skip to main content


Page 1 of 89

  1. Nafamostat mesylate is an anticoagulant used for critically ill patients during continuous kidney replacement therapy (CKRT), characterised by its short half-life. However, its optimal dosage remains unclear. ...

    Authors: Shinya Kameda, Akinori Maeda, Shun Maeda, Yutaro Inoue, Kazunari Takahashi, Akira Kageyama, Kent Doi and Tomoko Fujii
    Citation: BMC Nephrology 2024 25:69
  2. In Tunisia, the prevalence of diabetes mellitus increased from 15.5% on 2016 to 23% by 2023. While Chronic Kidney Disease (CKD) stills the most dreaded complications of diabetes, studies on the prevalence of c...

    Authors: Jannet Labidi, Amel Harzallah, Badereddine Ben Kaab, Ikram Mami, Sahar Agrebi, Awatef Azzabi, Soumaya Chargui, Mayssa Hadj-Brahim, Mouna Hammouda, Saifeddine Azaiez, Syrine Tlili, Olfa Lajili, Hela Antit, Yosra Hasni, Sarra Chenik, Farhat Chelbi…
    Citation: BMC Nephrology 2024 25:67
  3. IgG4-related disease (IgG4-RD) is a fibroinflammatory disease that affects multiple organs, including the pancreas, lacrimal glands, salivary glands, periaortic/retroperitoneum, and kidney. Interstitial nephri...

    Authors: Yusuke Ushio, Taro Akihisa, Kazunori Karasawa, Momoko Seki, Shizuka Kobayashi, Yoei Miyabe, Hiroshi Kataoka, Naoko Ito, Sekiko Taneda, Shin’ichi Akiyama, Akira Hebisawa, Mitsuhiro Kawano, Kazuho Honda and Junichi Hoshino
    Citation: BMC Nephrology 2024 25:66
  4. We devoted ourselves to proving that the initial transthoracic echocardiography score (TTES) had predictive significance for patients with continuous ambulatory peritoneal dialysis (CAPD).

    Authors: Sheng Wan, Yanglin Hu, Li Cheng, Da He, Zengsi Wang and Yanmin Zhang
    Citation: BMC Nephrology 2024 25:65
  5. Oxidative stress has been implicated in the pathogenesis of chronic kidney disease (CKD), prompting the exploration of antioxidants as a potential therapeutic avenue for mitigating disease progression. This st...

    Authors: Beibei Liu, Yanling Hu, Danyang Tian, Jianlong Dong and Bing-Feng Li
    Citation: BMC Nephrology 2024 25:64
  6. It is well known that asymptomatic hyperuricemia and gout play an important role in patients with chronic kidney disease (CKD). However, the effect of uric acid-lowering therapy (ULT) on the prognosis of CKD p...

    Authors: Yuxin Luo, Qirong Song, Jiaxiao Li, Sha Fu, Wenjuan Yu, Xiaofei Shao, Jinxiang Li, Yuliang Huang, Junzhe Chen and Ying Tang
    Citation: BMC Nephrology 2024 25:63
  7. The composition of organ preservation solutions is crucial for maintaining graft integrity and early graft function after transplantation. The aim of this study is to compare new organ preservation solution PE...

    Authors: Mohamed Bejaoui, Chérifa Slim, Carmen Peralta and Hassen Ben Abdennebi
    Citation: BMC Nephrology 2024 25:62
  8. Fabry disease (FD) is an uncommon, X-linked, lysosomal storage disease that causes defects in the glycosphingolipid metabolic pathway due to deficient or absent lysosomal α-galactosidase (α-Gal A) activity. Th...

    Authors: Zewei Chen, Bo Yin, Juan Jiao and Tianyang Ye
    Citation: BMC Nephrology 2024 25:61
  9. The consequences of chronic kidney disease (CKD) can be addressed with a range of pharmacotherapies primarily prescribed by nephrologists. More accurate information regarding future CKD-related pharmacotherapy...

    Authors: Eleni Stamellou, Turgay Saritas, Marc Froissart, Florian Kronenberg, Peter Stenvinkel, David C. Wheeler, Kai-Uwe Eckardt, Jürgen Floege and James Fotheringham
    Citation: BMC Nephrology 2024 25:60
  10. In Saudi Arabia (SA), there has been an alarming increase in the prevalence of chronic kidney diseases (CKD) over the last three decades. Despite being one of the largest countries in the Middle East, renal co...

    Authors: Mohammed Tawhari, Moustafa Alhamadh, Abdulrahman Alhabeeb, Abdulaziz Ureeg, Suliman Alghnam, Fayez Alhejaili, Lubna A. Alnasser and Abdullah Sayyari
    Citation: BMC Nephrology 2024 25:59
  11. Recent studies have suggested that ferroptosis participates in various renal diseases. However, its effect on focal segmental glomerulosclerosis remains unclear. This study analyzed the GSE125779 and GSE121211...

    Authors: Yanbin Lin, Jinxuan He, Zhixiang Mou, Huiting Chen, Wenkang You, Tianjun Guan and Lan Chen
    Citation: BMC Nephrology 2024 25:58
  12. Chronic kidney disease affects more than 10% of the world’s population and is a non-communicable disease of global concern and priority. There is a significant implementation gap between best practice guidelin...

    Authors: Hannah Wallace, Qiumian Wang, Tanita Botha, Barbara Hunter, Natalie Lumsden and Craig Nelson
    Citation: BMC Nephrology 2024 25:57
  13. Autosomal dominant polycystic kidney disease (ADPKD) is the leading inheritable cause of end-stage renal disease (ESRD). Mortality data specific to patients with ADPKD is currently lacking; thus, the aim of th...

    Authors: Deirdre Mladsi, Xiaolei Zhou, Gregory Mader, Myrlene Sanon, Jinyi Wang, Christine Barnett, Cynthia Willey and Stephen Seliger
    Citation: BMC Nephrology 2024 25:56
  14. The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have ...

    Authors: Kabir Jalal, Andre Charest, Xiaoyan Wu, Richard J. Quigg and Shirley Chang
    Citation: BMC Nephrology 2024 25:55
  15. Intravenous iron is commonly used in patients with non-dialysis-dependent chronic kidney disease (CKD). Modern intravenous iron compounds (e.g. ferric derisomaltose (FDI), ferric carboxymaltose (FCM)) are incr...

    Authors: Xenophon Kassianides and Sunil Bhandari
    Citation: BMC Nephrology 2024 25:54
  16. Minimal change nephrotic syndrome (MCNS) can be complicated by thymoma; however, no standard therapy for thymoma-associated MCNS has yet been established. We herein describe a case of steroid-resistant MCNS as...

    Authors: Yusaku Watanabe, Keiji Hirai, Momoko Hirata, Taisuke Kitano, Kiyonori Ito, Susumu Ookawara, Hisashi Oshiro and Yoshiyuki Morishita
    Citation: BMC Nephrology 2024 25:53
  17. The aim of this study was to investigate whether bioactive adrenomedullin (bio-ADM) and interleukin-6 (IL-6) are related to acute kidney injury (AKI) and severe illness in COVID-19 patients.

    Authors: Simon B. Leininger, Stephan T. Staudner, Manuel J. Vogel, Julian Mustroph, Ute Hubauer, Stefan Wallner, Petra Lehn, Ralph Burkhardt, Christine Meindl, Frank Hanses, Markus Zimmermann, Lars S. Maier, Julian Hupf and Carsten G. Jungbauer
    Citation: BMC Nephrology 2024 25:52
  18. Recent studies have focused on immune checkpoint inhibitors. Renal complications associated with the use of immune checkpoint inhibitors are uncommon compared with other immune-related adverse events. Acute in...

    Authors: Ryosuke Saiki, Kan Katayama, Haruko Saiki, Ayumi Fukumori, Kayo Tsujimoto, Masahiro Yamawaki, Fumika Tanaka, Daisuke Takahashi, Keiko Oda, Yasuo Suzuki, Tomohiro Murata and Kaoru Dohi
    Citation: BMC Nephrology 2024 25:51
  19. If any benefit is to be derived from the use of the health-related quality of life (HRQoL) questionnaires in chronic kidney disease (CKD) patients, they should be validated and culturally adapted to the target...

    Authors: Moustapha Faye, Florian Manneville, Adama Faye, Luc Frimat and Francis Guillemin
    Citation: BMC Nephrology 2024 25:50
  20. Sarcopenia is a common problem in hemodialysis (HD) patients, and it is diagnosed by low muscle mass, strength and/or low physical performance. Muscle ultrasound (US) is a non-invasive portable tool that might...

    Authors: Eman Nagy, Emad Samaan, Mohamed El-Gamal, Muhammed Shamsuddin and Samar Tharwat
    Citation: BMC Nephrology 2024 25:49
  21. This study aimed to investigate the association between cytochrome P450 (CYP) 3A4*22 and cytochrome P450 oxidoreductase (POR)*28 variations and the pharmacokinetics of tacrolimus.

    Authors: Ze Li, Xiaozhen Wang, Dandan Li, Sheng Cheng, Zhe Li, Heng Guo, Yiwen Dong, Yingming Zheng and Xingang Li
    Citation: BMC Nephrology 2024 25:48
  22. Chronic inflammation, reflected by an increased blood C-reactive protein (CRP) level, is common in patients with chronic kidney disease (CKD) and is involved in the development of renal anemia. This systematic...

    Authors: Xiaoyu Luo, Guoli Li, Hongyu Yang, Lang Chen, Yinyan Gao, Jing Cong, Hui Luo and Weiru Zhang
    Citation: BMC Nephrology 2024 25:47
  23. The psychological problems of hemodialysis (HD) patients are prominent, and benefit finding (BF) have been proven beneficial to physical and mental health, fewer researchers explored BF in HD patients. The aim...

    Authors: Jie Yang, Hong-Li Yan, Yong-Qi Li, Lei Zhang, Xiao-Yan Qiu, Yi-He Tian, Yan-Lin Gong, Chen-Ling Luo, Jing Wu and Jing Chu
    Citation: BMC Nephrology 2024 25:46
  24. Individuals with chronic kidney disease experience difficult physical and psychological symptoms, that impact quality of life, and are at increased risk of anxiety and depression. Access to specialist psycholo...

    Authors: Anna Wilson, Claire Carswell, Clare McKeaveney, Karen Atkinson, Stephanie Burton, Clare McVeigh, Lisa Graham-Wisener, Erika Jääskeläinen, William Johnston, Daniel O’Rourke, Joanne Reid, Soham Rej, Ian Walsh and Helen Noble
    Citation: BMC Nephrology 2024 25:45
  25. Chronic kidney disease (CKD) is a major public health issue with an increasing incidence and prevalence worldwide. In CKD, hematological parameters are influenced, and the effect increases with CKD stage. Thus...

    Authors: Melaku Shenkut, Fekadu Urgessa, Rahel Alemu and Bezaye Abebe
    Citation: BMC Nephrology 2024 25:44
  26. NGAL and Cystatin C (CysC) as biomarkers for the early detection of AKI are subject to both pathophysiological, as well as patient related heterogeneity. The aim of this study was to investigate the timeline o...

    Authors: Daniela Jou-Valencia, Meint Volbeda, Jan G. Zijlstra, Jenny E Kootstra-Ros, Jill Moser, Matijs van Meurs and Jacqueline Koeze
    Citation: BMC Nephrology 2024 25:43
  27. Despite several clinical trials, the use of corticosteroid therapy for treating immunoglobulin A nephropathy (IgAN) remains controversial. We aimed to describe the use of corticosteroid therapy combined with s...

    Authors: Mariell Rivedal, Yngvar Lunde Haaskjold, Øystein Eikrem, Rune Bjørneklett, Hans Peter Marti and Thomas Knoop
    Citation: BMC Nephrology 2024 25:42
  28. Respiratory sarcopenia is characterized by the weakness of respiratory muscles associated with sarcopenia due to aging or systemic diseases such as chronic kidney disease (CKD). Patients with CKD undergoing di...

    Authors: Francini Porcher Andrade, Sheila Borges, César Alencar da Silva Filho, Taís Ferreira Martins, Heloíse Benvenutti, Júlia de Melo Cardoso de Freitas, Fernando Saldanha Thomé, Cristina Karohl, Gabriela Correa Souza, Graziella França Bernardelli Cipriano and Paula Maria Eidt Rovedder
    Citation: BMC Nephrology 2024 25:41
  29. Patient reported experience measures are contemporary quality indicators that focus on evaluation of healthcare delivery processes. While surgical arteriovenous fistulas (otherAVF) are preferred for haemodialy...

    Authors: Melanie Field, A. Z. Khawaja, J. Ellis, R. G. Jones and N. G. Inston
    Citation: BMC Nephrology 2024 25:38
  30. Patients taking SGLT-2 inhibitors may experience delayed peritoneal fibrosis, better ultrafiltration of water and toxins, and higher survival rates. We aimed to evaluate the possible effects of Dapagliflozin i...

    Authors: Zakaria Hamdan, Yusri Abdel-Hafez, Ahmad Enaya, Alaa Sarsour, Lubna Kharraz and Zaher Nazzal
    Citation: BMC Nephrology 2024 25:37
  31. The objective of this study is to investigate the clinical and pathological differences between patients with IgA nephropathy (IgAN) and IgA vasculitis associated nephritis (IgAVN).

    Authors: Yinhong Wang, Hao Wang, Xiaotao Ma, Zikun Zhu, Xuefei Tian, Rongguo Fu and Lining Jia
    Citation: BMC Nephrology 2024 25:35
  32. Diabetic kidney diseases (DKD) is a the most common cause of end-stage kidney disease (ESKD) around the world. Previous studies suggest that urinary podocyte stress biomarker, e.g. podocin:nephrin mRNA ratio, ...

    Authors: Lingfeng Zeng, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow and Cheuk-Chun Szeto
    Citation: BMC Nephrology 2024 25:32
  33. The psychosocial assessment is an essential component of the living kidney donor (LKD) evaluation. However, it remains uncertain how specific psychosocial factors impact LKD eligibility. We performed a retrosp...

    Authors: Liza K. Cholin, Everly F. Ramos, Jordana Yahr, Jesse D. Schold, Emilio D. Poggio, Christina L. Delvalle and Anne M. Huml
    Citation: BMC Nephrology 2024 25:31
  34. Hemodialysis patients are prone to anxiety and depression due to physiological changes and psychological tensions that leave irreversible effects on the patients. In this regard, the present study was an attem...

    Authors: Tahereh Hosseini, Manijeh Hooshmandja, Morteza Noaparast, Rita Mojtahedzadeh and Aeen Mohammadi
    Citation: BMC Nephrology 2024 25:30
  35. Evidence of willingness to pay for kidney replacement therapy is scarce in low-middle-income countries, including Nigeria’s Formal Sector Social Health Insurance Programme. The study, therefore, assessed the w...

    Authors: Yakubu Adole Agada-Amade, Daniel Chukwuemeka Ogbuabor, Eric Obikeze, Ejemai Eborieme and Obinna Emmanuel Onwujekwe
    Citation: BMC Nephrology 2024 25:29
  36. To construct and validate a prediction model of the risk of citrate accumulation in patients with hepatic dysfunction receiving continuous renal replacement therapy with regional citrate anticoagulation (RCA-C...

    Authors: Quxia Hong, Siyu Chen, Yongchun He, Jianghua Chen and Ping Zhang
    Citation: BMC Nephrology 2024 25:27
  37. Up to now, there is no unequivocal intervention to mitigate vascular calcification (VC) in patients with hemodialysis. This network meta-analysis aimed to systematically evaluate the clinical efficacy of sodiu...

    Authors: Lei He, Yuzhe Li, Jingjing Jin, Meijuan Cheng, Yaling Bai and Jinsheng Xu
    Citation: BMC Nephrology 2024 25:26
  38. Fibronectin (FN) glomerulopathy (FNG), a rare autosomal hereditary renal disease, is characterized by proteinuria resulting from the massive accumulation of FN in the glomeruli. It typically affects individual...

    Authors: Misa Hata, Takayasu Mori, Yurika Hirose, Yuriko Nishida, Shintaro Mandai, Fumiaki Ando, Koichiro Susa, Soichiro Iimori, Shotaro Naito, Eisei Sohara, Tatemitsu Rai, Towako Taguchi, Shohei Tomii, Kenichi Ohashi and Shinichi Uchida
    Citation: BMC Nephrology 2024 25:25
  39. This narrative review highlights strategies proposed by the Mexican Group of Experts on Arterial Hypertension endorsed to prevent, diagnose, and treat chronic kidney disease (CKD) related to systemic arterial ...

    Authors: Silvia Palomo-Piñón, José Manuel Enciso-Muñoz, Eduardo Meaney, Ernesto Díaz-Domínguez, David Cardona-Muller, Fabiola Pazos Pérez, Emilia Cantoral-Farfán, Juan Carlos Anda-Garay, Janet Mijangos-Chavez and Neftali Eduardo Antonio-Villa
    Citation: BMC Nephrology 2024 25:24
  40. We aimed to explore the three-way interaction among age, gender, and kidney function on the risk of all-cause mortality and cardiovascular mortality among patients with type 2 diabetes (T2D).

    Authors: Tazeen H. Jafar, Loraine Liping Seng, Yeli Wang, Ching Wee Lim, Choong Meng Chan, Jia Liang Kwek, Thomas M. Coffman, Yongjing Ping, Yong Mong Bee and John C. Allen
    Citation: BMC Nephrology 2024 25:23
  41. Previous Mendelian studies identified a causal relationship between renal function, as assessed by estimated glomerular filtration rate (eGFR), and severe infection with coronavirus disease 2019 (COVID-19). Ho...

    Authors: Qiuling Li, Mengjiao Lin, Yinghui Deng and Haozhang Huang
    Citation: BMC Nephrology 2024 25:21
  42. End-stage renal disease (ESRD) is a growing cause of morbidity worldwide. Protein malnutrition is common among patients with ESRD. Peritoneal dialysis (PD) offers greater lifestyle flexibility and independence...

    Authors: Iyad Ali, Dania Haddad, Mostafa A. Soliman, Ahmed Al-Sabi, Kamel Jebreen, Dana Abuzahra, Bakrieh Shrara, Diana Ghanayem, Nihal Natour, Mohanad Hassan, M. Yasser Alsedfy, Duha Shellah and Inad Nawajah
    Citation: BMC Nephrology 2024 25:20

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    2.3 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.064 - SNIP (Source Normalized Impact per Paper)
    0.746 - SJR (SCImago Journal Rank)

    2022 Speed
    30 days submission to first editorial decision for all manuscripts (Median)
    155 days submission to accept (Median)

    2022 Usage 
    6,694 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal